阳普医疗收盘下跌1.28%，最新市净率3.11，总市值19.14亿元

Group 1 - The core viewpoint of the news is that Yangpu Medical's stock has experienced a decline, with a closing price of 6.19 yuan and a market capitalization of 1.914 billion yuan, indicating a challenging financial environment for the company [1] - The company reported a net outflow of 2.582 million yuan in principal funds on May 28, with a total outflow of 8.2771 million yuan over the past five days, suggesting negative investor sentiment [1] - Yangpu Medical specializes in precision medicine, smart healthcare, and testing services, with its main product being a specimen management system [1] Group 2 - For the first quarter of 2025, Yangpu Medical achieved an operating income of 116 million yuan, a year-on-year decrease of 18.15%, while net profit was 7.8084 million yuan, showing a significant year-on-year increase of 344.71%, with a gross profit margin of 40.19% [1] - The company's price-to-earnings (P/E) ratio is reported at -17.90 (TTM) and -16.23 (static), with a price-to-book (P/B) ratio of 3.11, compared to the industry average P/E of 48.81 and P/B of 4.62 [2] - The total market capitalization of Yangpu Medical is 1.914 billion yuan, which is lower than the industry median market capitalization of 4.869 billion yuan [2]